Trial Profile
REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2023
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Acronyms SMART REWARD
- 06 Feb 2023 Results of pooled analysis(n=1003 from two studies NCT02601404, NCT04265443) assessing mid-term safety and efficacy of Absorb BVS with meticulous device optimization under intravascular imaging guidance published in the Journal of Korean Medical Science
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.
- 13 Nov 2015 New trial record